180 related articles for article (PubMed ID: 18069758)
1. Heterozygous nucleotide-binding oligomerization domain-2 mutations affect monocyte maturation in Crohn's disease.
Granzotto M; Fabbro E; Maschio M; Martelossi S; Quaglia S; Tommasini A; Presani G; Ventura A
World J Gastroenterol; 2007 Dec; 13(46):6191-6. PubMed ID: 18069758
[TBL] [Abstract][Full Text] [Related]
2. MDP-Induced selective tolerance to TLR4 ligands: impairment in NOD2 mutant Crohn's disease patients.
Cantó E; Moga E; Ricart E; Garcia-Bosch O; Garcia-Planella E; Juarez C; Vidal S
Inflamm Bowel Dis; 2009 Nov; 15(11):1686-96. PubMed ID: 19572373
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptor-induced granulocyte-macrophage colony-stimulating factor secretion is impaired in Crohn's disease by nucleotide oligomerization domain 2-dependent and -independent pathways.
Brosbøl-Ravnborg A; Hvas CL; Agnholt J; Dahlerup JF; Vind I; Till A; Rosenstiel P; Höllsberg P
Clin Exp Immunol; 2009 Mar; 155(3):487-95. PubMed ID: 19094116
[TBL] [Abstract][Full Text] [Related]
4. NOD2/CARD15 genotype influences MDP-induced cytokine release and basal IL-12p40 levels in primary isolated peripheral blood monocytes.
Beynon V; Cotofana S; Brand S; Lohse P; Mair A; Wagner S; Mussack T; Ochsenkühn T; Folwaczny M; Folwaczny C; Glas J; Török HP
Inflamm Bowel Dis; 2008 Aug; 14(8):1033-40. PubMed ID: 18383179
[TBL] [Abstract][Full Text] [Related]
5. Muramyl dipeptide-induced differential gene expression in NOD2 mutant and wild-type Crohn's disease patient-derived dendritic cells.
Zelinkova Z; van Beelen AJ; de Kort F; Moerland PD; Ver Loren van Themaat E; te Velde AA; van Deventer SJ; de Jong EC; Hommes DW
Inflamm Bowel Dis; 2008 Feb; 14(2):186-94. PubMed ID: 17941075
[TBL] [Abstract][Full Text] [Related]
6. Species-specific engagement of human nucleotide oligomerization domain 2 (NOD)2 and Toll-like receptor (TLR) signalling upon intracellular bacterial infection: role of Crohn's associated NOD2 gene variants.
Salem M; Seidelin JB; Eickhardt S; Alhede M; Rogler G; Nielsen OH
Clin Exp Immunol; 2015 Mar; 179(3):426-34. PubMed ID: 25335775
[TBL] [Abstract][Full Text] [Related]
7. CARD15 variants determine a disturbed early response of monocytes to adherent-invasive Escherichia coli strain LF82 in Crohn's disease.
Peeters H; Bogaert S; Laukens D; Rottiers P; De Keyser F; Darfeuille-Michaud A; Glasser AL; Elewaut D; De Vos M
Int J Immunogenet; 2007 Jun; 34(3):181-91. PubMed ID: 17504508
[TBL] [Abstract][Full Text] [Related]
8. Differential effect of vitamin D on NOD2- and TLR-induced cytokines in Crohn's disease.
Dionne S; Calderon MR; White JH; Memari B; Elimrani I; Adelson B; Piccirillo C; Seidman EG
Mucosal Immunol; 2014 Nov; 7(6):1405-15. PubMed ID: 24781050
[TBL] [Abstract][Full Text] [Related]
9. Altered pattern of tumor necrosis factor-alpha production in peripheral blood monocytes from Crohn's disease.
Loganes C; Pin A; Naviglio S; Girardelli M; Bianco AM; Martelossi S; Tommasini A; Piscianz E
World J Gastroenterol; 2016 Nov; 22(41):9117-9126. PubMed ID: 27895399
[TBL] [Abstract][Full Text] [Related]
10. Impaired dendritic cell function in Crohn's disease patients with NOD2 3020insC mutation.
Kramer M; Netea MG; de Jong DJ; Kullberg BJ; Adema GJ
J Leukoc Biol; 2006 Apr; 79(4):860-6. PubMed ID: 16461743
[TBL] [Abstract][Full Text] [Related]
11. Impaired antibacterial autophagy links granulomatous intestinal inflammation in Niemann-Pick disease type C1 and XIAP deficiency with NOD2 variants in Crohn's disease.
Schwerd T; Pandey S; Yang HT; Bagola K; Jameson E; Jung J; Lachmann RH; Shah N; Patel SY; Booth C; Runz H; Düker G; Bettels R; Rohrbach M; Kugathasan S; Chapel H; Keshav S; Elkadri A; Platt N; Muise AM; Koletzko S; Xavier RJ; Marquardt T; Powrie F; Wraith JE; Gyrd-Hansen M; Platt FM; Uhlig HH
Gut; 2017 Jun; 66(6):1060-1073. PubMed ID: 26953272
[TBL] [Abstract][Full Text] [Related]
12. NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation.
Cooney R; Baker J; Brain O; Danis B; Pichulik T; Allan P; Ferguson DJ; Campbell BJ; Jewell D; Simmons A
Nat Med; 2010 Jan; 16(1):90-7. PubMed ID: 19966812
[TBL] [Abstract][Full Text] [Related]
13. Crohn's disease-associated polymorphism within the PTPN2 gene affects muramyl-dipeptide-induced cytokine secretion and autophagy.
Scharl M; Mwinyi J; Fischbeck A; Leucht K; Eloranta JJ; Arikkat J; Pesch T; Kellermeier S; Mair A; Kullak-Ublick GA; Truninger K; Noreen F; Regula J; Gaj P; Pittet V; Mueller C; Hofmann C; Fried M; McCole DF; Rogler G
Inflamm Bowel Dis; 2012 May; 18(5):900-12. PubMed ID: 22021207
[TBL] [Abstract][Full Text] [Related]
14. NOD2 modulates immune tolerance via the GM-CSF-dependent generation of CD103
Prescott D; Maisonneuve C; Yadav J; Rubino SJ; Girardin SE; Philpott DJ
Proc Natl Acad Sci U S A; 2020 May; 117(20):10946-10957. PubMed ID: 32350141
[TBL] [Abstract][Full Text] [Related]
15. The effect of NOD2 activation on TLR2-mediated cytokine responses is dependent on activation dose and NOD2 genotype.
Borm ME; van Bodegraven AA; Mulder CJ; Kraal G; Bouma G
Genes Immun; 2008 Apr; 9(3):274-8. PubMed ID: 18340358
[TBL] [Abstract][Full Text] [Related]
16. ATG16L1 and NOD2 interact in an autophagy-dependent antibacterial pathway implicated in Crohn's disease pathogenesis.
Homer CR; Richmond AL; Rebert NA; Achkar JP; McDonald C
Gastroenterology; 2010 Nov; 139(5):1630-41, 1641.e1-2. PubMed ID: 20637199
[TBL] [Abstract][Full Text] [Related]
17. Synergistic effect of Nod1 and Nod2 agonists with toll-like receptor agonists on human dendritic cells to generate interleukin-12 and T helper type 1 cells.
Tada H; Aiba S; Shibata K; Ohteki T; Takada H
Infect Immun; 2005 Dec; 73(12):7967-76. PubMed ID: 16299289
[TBL] [Abstract][Full Text] [Related]
18. Down-regulated NOD2 by immunosuppressants in peripheral blood cells in patients with SLE reduces the muramyl dipeptide-induced IL-10 production.
Yu SL; Wong CK; Wong PT; Chen DP; Szeto CC; Li EK; Tam LS
PLoS One; 2011; 6(8):e23855. PubMed ID: 21886831
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of Muramyl Dipeptide-Dependent NOD2 Activity by a Self-Derived Peptide.
Mann JK; Shen J; Park S
J Cell Biochem; 2017 May; 118(5):1227-1238. PubMed ID: 27791288
[TBL] [Abstract][Full Text] [Related]
20. ATG16L1 and NOD2 polymorphisms enhance phagocytosis in monocytes of Crohn's disease patients.
Wolfkamp SC; Verseyden C; Vogels EW; Meisner S; Boonstra K; Peters CP; Stokkers PC; te Velde AA
World J Gastroenterol; 2014 Mar; 20(10):2664-72. PubMed ID: 24627602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
